Literature DB >> 17397765

Jon Van Rood: pioneer at the crossroad of human leukocyte antigens and transplantation.

Jan Jansen1.   

Abstract

Jon Van Rood (born in 1926) has made major contributions to the fields of transfusion medicine as well as organ and stem cell transplantation. His group was the first to start unraveling the complexity of the human leukocyte antigen (HLA) system through collaborative studies that used panels of sera and leukocyte samples. Furthermore, using HLA typing, he introduced the first HLA-matched platelet transfusions and developed routine leukocyte depletion as a means to prevent HLA alloimmunization. Van Rood has also been active in the fields of kidney transplantation (Eurotransplant) and stem cell transplantation (Europdonor). He combined scientific laboratory research with application to clinical medicine. He retired from his university position in 1991 but remains active in the field.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397765     DOI: 10.1016/j.tmrv.2006.11.006

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  1 in total

1.  Novel surgical techniques, regenerative medicine, tissue engineering and innovative immunosuppression in kidney transplantation.

Authors:  Maciej Nowacki; Łukasz Nazarewski; Tomasz Kloskowski; Dominik Tyloch; Marta Pokrywczyńska; Katarzyna Pietkun; Arkadiusz Jundziłł; Janusz Tyloch; Samy L Habib; Tomasz Drewa
Journal:  Arch Med Sci       Date:  2016-08-25       Impact factor: 3.318

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.